Daranide

Daranide

 [dar´ah-nīd]
trademark for a preparation of dichlorphenamide, a carbonic anhydrase inhibitor used in treatment of glaucoma.
References in periodicals archive ?
The drug Anderson has been taking all these years was originally approved in 1958 and used primarily to treat the eye disease glaucoma under the brand name Daranide, its price so unremarkable that he can't quite remember how much it cost at the pharmacy counter.
The zigzagging trajectory of the price of Daranide, now known as Keveyis, shows just how much freedom drug companies have in pricing therapies -- and what a big business opportunity selling extremely-rare-disease drugs has become.
Daranide was approved half a century ago, often used to treat glaucoma.
In the early 2000s, Daranide was discontinued by Merck.
In 2008, a family affected by the disease that also owned Taro Pharmaceutical Industries, a generic pharmaceutical company, decided to acquire Daranide from Merck.
Senators Susan Collins (R-ME), Amy Klobuchar (D-MN), and Tammy Baldwin (D-WI) have pressed Strongbridge Biopharma for answers on the dramatic price increase for Keveyis, formerly known as Daranide, a drug that treats glaucoma and a type of rare genetic disease known as periodic paralysis, which causes attacks of muscle weakness or loss of muscle movement.
We are writing to express our deep concern regarding the dramatic price increase for Keveyis, formerly known as Daranide, after Strongbridge Biopharma acquired the drug.
Diuretics (water pills) listed in the 2005 Physicians' Desk Reference include Daranide, Dyazide, Maxzide, Moduretic, Demadex, Edecrin, Furosemide, Dyrenium, Midamor, Diuril, Indapamide, Microzide, Renese, and Zaroxolyn.
Senators Amy Klobuchar (D-MN), Susan Collins (R-ME), and Tammy Baldwin (D-WI) have pressed Strongbridge Biopharma for answers on the dramatic price increase for Keveyis, formerly known as Daranide, a drug that treats glaucoma and a type of rare genetic disease known as periodic paralysis, which causes attacks of muscle weakness or loss of muscle movement.
Senator Tammy Baldwin, a member of the Senate Health, Education, Labor and Pensions (HELP) Committee, joined Senators Amy Klobuchar (D-MN) and Susan Collins (R-ME) in pressing Strongbridge Biopharma for answers on dramatic price increases for Keveyis, formerly known as Daranide.